関連する実験動画
Updated: Sep 9, 2025
11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.5K
メラノーマ細胞のフェノタイプスイッチングにおけるARHGAP29の新たな役割
Beatrice Charlotte Tröster1, Melanie Kappelmann-Fenzl1,2, Anja Katrin Bosserhoff1,3,4
1Institute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Molecular oncology
|September 4, 2025
まとめ
Rho GTPase活性化タンパク質29 (ARHGAP29) は,RhoA/ ROCK経路と細胞の可塑性を調節することによって,メラノーマ細胞の侵入を促進します. この研究では,ARHGAP29がメラノーマの進行の主要な原動力であり,潜在的な治療目標であると特定されています.
科学分野:
- 腫瘍学
- 細胞生物学
- 分子生物学
背景:
- Rho GTPase活性化タンパク質29 (ARHGAP29) は,アクチン細胞骨格を調節し,非メラノーマがんの侵入を促進することが知られている.
- 皮膚がんであるメラノーマにおけるARHGAP29の機能は未定でした.
- トランスクリプトミア分析により,正常なメラノサイトと比較して,メラノーマ細胞系におけるARHGAP29発現が著しく高かったことが明らかになった.
研究 の 目的:
- メラノーマにおけるARHGAP29の機能的役割を調査する.
- ARHGAP29がメラノーマ細胞の移動と進行に影響を与えるかどうかを判断する.
- メラノーマにおけるARHGAP29による下流信号伝達経路の解明
主な方法:
- ARHGAP29発現を比較するトランスクリプトミックの分析
- メラノーマの細胞系でのARHGAP29ノックダウン実験
- 細胞形態の評価,移動,およびRhoA/ROCK経路の活動
- SMAD活動と腫瘍細胞の可塑性に対するARHGAP29の効果の調査.
主要な成果:
- ARHGAP29の発現はメラノーマ細胞で上調される.
- ARHGAP29のノックダウンにより,細胞形態が変化し,発散の少ないフェノタイプが生まれました.
- ARHGAP29はRhoA/ROCKシグナル伝達経路を調節する.
- ARHGAP29はSMADの活動に影響を与え,腫瘍細胞の可塑性を高めるメゼンキマのような侵入性フェノタイプを促進します.
結論:
- ARHGAP29はメラノーマ細胞の侵入と進行を促進する上で重要な役割を果たします.
- RhoA/ ROCK経路とSMAD活動は,メラノーマにおけるARHGAP29の主要な下流効果因子である.
- ARHGAP29はメラノーマの治療における新しい有望な治療目標です.
関連する概念動画
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:21Cell Polarization by Rho Proteins
2.8K
Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
2.8K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
01:24Small GTPases - Ras and Rho
4.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.2K